Ariel Investments
Ariel Focused Value
Mid-cap Value
Dec 2025 → Mar 2026
Our archive holds 2 letters from this strategy, behind 5 investment theses and positions in 11 companies. Every quote below is copied verbatim from the letter it came from.
2 letters in 2 years · follow all of Ariel Investments for every strategy.
What it bought and sold
Also during the quarter, we initiated a position in FactSet Research Systems (FDS), a leading provider of information and analytics to the global financial services industry.
By comparison, we successfully exited global investment bank, Goldman Sachs Group, Inc. (GS), on valuation as shares began trading above our estimate of private market value.
Additionally, we repurchased Bio-Rad Laboratories Inc. (BIO), a global leader in laboratory equipment and biological testing.
Also held
Its investment theses
- Bio-Rad Laboratories Inc.Mar 2026Bio-Rad Laboratories Inc. is a global life sciences tools leader with rising margins, high recurring revenue, and dominant market positions supporting long-term growth.
- FactSet Research Systems Inc.Mar 2026FactSet Research Systems Inc. is an embedded financial data and analytics provider with high switching costs and recurring revenues poised to benefit from AI-driven efficiencies.
- Fiserv, Inc.Dec 2025Fiserv is a leading payments and fintech provider with scale, high switching costs and recurring revenue, resetting expectations ahead of long-term digital payments growth.
- ADT Inc.Dec 2025ADT Inc. is a leading security provider with unmatched brand, recurring revenue and strategic partnerships that underpin a durable moat and long-term growth from smart home adoption.
- Resideo Technologies, Inc.Dec 2025Resideo Technologies is a residential comfort and security solutions provider with transitory headwinds, a value-unlocking ADI spin-off, and scale-driven opportunities for margin expansion.